After announcing he was cancer-free over the summer, Hall of Fame second baseman Ryne Sandberg says disease is back and has ...

Adoption of active surveillance or watchful waiting has been increasing among patients with intermediate-risk prostate cancer ...

In most countries, prostate cancer incidence and mortality rates decreased or were stable in the most recent five-year period ...

Research by Cancer Center genetic epidemiologist Burcu Darst, PhD, and scientists from the Canary Prostate Active ...

A new study found that a DNA sequencing test for advanced prostate cancer patients can distinguish between patients with poor and favorable prognoses.

Published in Nature Communications, a new study led by the University of Minnesota Medical School and Duke University found ...

The phase III study enrolled intermediate-to-high-risk, localized prostate cancer patients who either received the combination therapy of CAN-2409+prodrug (valacyclovir)+SOC or SOC alone. The study ...

Candel’s trial was conducted under the FDA’s Special Protocol Assessment program, meaning that its data could be used as a ...

A phase 3 prostate cancer trial of Candel’s oncolytic virus has met its primary endpoint, sending the stock up more than 200% ...

Former Formula One team owner Eddie Jordan has revealed he was diagnosed with an “aggressive” form of cancer earlier this ...

Prostate cancer vaccines, including dendritic and peptide types, offer hope for improved treatments, but face hurdles in ...

African men have a high risk of prostate cancer. Research has found genetic regions associated with this disease.